Phase I Clinical Study of Tumor-associated Lymph Node T Cell Therapy for Advanced Solid Tumors

Conditions: Advanced Solid Tumor; Tumor Associated Lymph Node T Cell; Immunotherapy Interventions: Drug: Tumor Associated Lymph node T cell; Drug: cyclophosphamide; Drug: IL-2; Drug: Serplulimab Injection Sponsors: Guangzhou FineImmune Biotechnology Co., LTD. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials